cached image

Philip Scheltens, MD PhD

Alzheimer Center VU University Medical Center, Amsterdam, Netherlands 
dementia, MRI, CSF, PET, http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=111
"Philip Scheltens"





Mean distance: 16.41 (cluster 44)
Cross-listing: Alzheimer's Tree


Sign in to add mentor
Johan Carel Koetsier grad student 1993 VU Amsterdam
Jaap Valk grad student 1993 VU Amsterdam
 (MR imaging in Alzheimer's disease)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

van Engelen ME, Rozemuller AJM, Ulugut Erkoyun H, et al. (2021) The bvFTD phenocopy syndrome: a case study supported by repeated MRI, [F]FDG-PET and pathological assessment. Neurocase. 1-9
Singleton E, Hansson O, Pijnenburg YAL, et al. (2021) Heterogeneous distribution of tau pathology in the behavioural variant of Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry
Briels CT, Stam CJ, Scheltens P, et al. (2021) The predictive value of normal EEGs in dementia due to Alzheimer's disease. Annals of Clinical and Translational Neurology
Collij LE, Ingala S, Top H, et al. (2021) White matter microstructure disruption in early stage amyloid pathology. Alzheimer's & Dementia (Amsterdam, Netherlands). 13: e12124
Ingala S, De Boer C, Masselink LA, et al. (2021) Application of the ATN classification scheme in a population without dementia: Findings from the EPAD cohort. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Shi L, Winchester LM, Westwood S, et al. (2021) Replication study of plasma proteins relating to Alzheimer's pathology. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Collij LE, Salvadó G, Shekari M, et al. (2021) Visual assessment of [F]flutemetamol PET images can detect early amyloid pathology and grade its extent. European Journal of Nuclear Medicine and Molecular Imaging
Cicognola C, Hansson O, Scheltens P, et al. (2021) Cerebrospinal fluid N-224 tau helps discriminate Alzheimer's disease from subjective cognitive decline and other dementias. Alzheimer's Research & Therapy. 13: 38
Coomans EM, Schoonhoven DN, Tuncel H, et al. (2021) In vivo tau pathology is associated with synaptic loss and altered synaptic function. Alzheimer's Research & Therapy. 13: 35
Beker N, Ganz A, Hulsman M, et al. (2021) Association of Cognitive Function Trajectories in Centenarians With Postmortem Neuropathology, Physical Health, and Other Risk Factors for Cognitive Decline. Jama Network Open. 4: e2031654
See more...